Wednesday, October 7, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 10, 2026

ING rolls out global subscription banking model

View original at globenewswire.com
ING rolls out global subscription banking model ING rolls out global subscription banking model ING today announced a new global subscriptions model designed to make daily banking easier and deliver greater value for customers…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • There are already 3 million customers enjoying the benefits of the new subscription plans, including customers migrated from existing offerings

    60% confidence

  • MSCI upgraded ING's ESG rating from 'AA' to 'AAA' in October 2025

    60% confidence

  • ING's customer research shows a growing demand for simplicity, transparency, and benefits that fit everyday life

    60% confidence

  • Customers want everyday banking to be simpler, designed around their lifestyle and with more flexibility, based on extensive customer research

    60% confidence

  • The subscription model move marks an important step in ING's strategy to evolve from product-based banking towards more relationship-based customer propositions

    60% confidence

  • ING is already seeing strong early interest from customers in the markets where the subscription model has launched

    60% confidence

  • ING's management of ESG material risk is 'Strong' with an ESG risk rating of 18.0 (low risk)

    60% confidence

  • ING sees a real opportunity to create value for customers and acted on growing customer demand for simplicity, transparency and lifestyle-aligned benefits

    60% confidence

Data points we hold from this source

ING Group · cash600 USD
ING Group · market share41 millions_customers
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com